J Arnt|J Hyttel - JoVE Visualize

Showing results (21-30 of 111) with videos related to

Pageof 12

Sort By:

Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1985

Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brainJ Arnt, A V Christensen, J Hyttel

Journal of Neural Transmission|January 1, 1985

Down-regulation of dopamine D-2, 5-HT2 receptors and beta-adrenoceptors in rat brain after prolonged treatment with a new potential antidepressant, Lu 19-005G Nowak, J Arnt, J Hyttel, et al.

Polish Journal of Pharmacology and Pharmacy|March 1, 1984

Behavioural correlates to the dopamine D-1 and D-2 antagonistsA V Christensen, J Arnt, J Hyttel, et al.

Pharmacology & Toxicology|March 1, 1988

Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in ratsJ Arnt, K P Bøgesø, J Hyttel, et al.

Journal of Medicinal Chemistry|September 17, 1993

Stereospecific and selective 5-HT2 antagonism in a series of 5-substituted trans-1-piperazino-3-phenylindansK P Bøgesø, J Arnt, J Hyttel, et al.

Psychopharmacology|January 1, 1993

The role of serotonergic mechanisms in inhibition of isolation-induced aggression in male miceC Sánchez, J Arnt, J Hyttel, et al.

Psychopharmacology|January 1, 1984

Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopramJ Arnt, K F Overø, J Hyttel, et al.

Psychopharmacology. Supplementum|January 1, 1985

Receptor-binding profiles of neurolepticsJ Hyttel, J J Larsen, A V Christensen, et al.

Journal of Medicinal Chemistry|March 20, 1992

Noncataleptogenic, centrally acting dopamine D-2 and serotonin 5-HT2 antagonists within a series of 3-substituted 1-(4-fluorophenyl)-1H-indolesJ Perregaard, J Arnt, K P Bøgesø, et al.

Journal of Medicinal Chemistry|July 1, 1991

Octoclothepin enantiomers. A reinvestigation of their biochemical and pharmacological activity in relation to a new receptor-interaction model for dopamine D-2 receptor antagonistsK P Bøgesø, T Liljefors, J Arnt, et al.

Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:

Pageof 12

Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1985

Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brainJ Arnt, A V Christensen, J Hyttel

Journal of Neural Transmission|January 1, 1985

Down-regulation of dopamine D-2, 5-HT2 receptors and beta-adrenoceptors in rat brain after prolonged treatment with a new potential antidepressant, Lu 19-005G Nowak, J Arnt, J Hyttel, et al.

Polish Journal of Pharmacology and Pharmacy|March 1, 1984

Behavioural correlates to the dopamine D-1 and D-2 antagonistsA V Christensen, J Arnt, J Hyttel, et al.

Pharmacology & Toxicology|March 1, 1988

Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in ratsJ Arnt, K P Bøgesø, J Hyttel, et al.

Journal of Medicinal Chemistry|September 17, 1993

Stereospecific and selective 5-HT2 antagonism in a series of 5-substituted trans-1-piperazino-3-phenylindansK P Bøgesø, J Arnt, J Hyttel, et al.

Psychopharmacology|January 1, 1993

The role of serotonergic mechanisms in inhibition of isolation-induced aggression in male miceC Sánchez, J Arnt, J Hyttel, et al.

Psychopharmacology|January 1, 1984

Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopramJ Arnt, K F Overø, J Hyttel, et al.

Psychopharmacology. Supplementum|January 1, 1985

Receptor-binding profiles of neurolepticsJ Hyttel, J J Larsen, A V Christensen, et al.

Journal of Medicinal Chemistry|March 20, 1992

Noncataleptogenic, centrally acting dopamine D-2 and serotonin 5-HT2 antagonists within a series of 3-substituted 1-(4-fluorophenyl)-1H-indolesJ Perregaard, J Arnt, K P Bøgesø, et al.

Journal of Medicinal Chemistry|July 1, 1991

Octoclothepin enantiomers. A reinvestigation of their biochemical and pharmacological activity in relation to a new receptor-interaction model for dopamine D-2 receptor antagonistsK P Bøgesø, T Liljefors, J Arnt, et al.

Pageof 12